FindMyKOL

Luke Pater, MD

Enriched profile

Professor of Clinical, Radiation Oncology, College of Medicine (University of Cincinnati) · University of Cincinnati

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Cincinnati, OH · Midwest · United StatesSpecialtyRadiation OncologyFocusGlioma Diagnosis and Treatment+4
Last active 2022FindMyKOL type: RegionalLatest publication2026Online presenceNone verifiedPayments2022–2022NIH fundingNone on fileWhy? →

Luke Pater is Professor of Clinical, Radiation Oncology, College of Medicine (University of Cincinnati) at University of Cincinnati. OpenAlex indexes 74 publications with 1,646 citations (h-index 16); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 27 Oct 2026

Overview

Updated 30 Oct 2026

Luke Pater, MD, is Professor of Clinical, Radiation Oncology, College of Medicine (University of Cincinnati). The public record shows 74 publications with 1,646 citations (h-index 16), centered on Glioma Diagnosis and Treatment, Radiation Therapy and Dosimetry, Sarcoma Diagnosis and Treatment. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 1 companies.

  • Top research focus: Glioma Diagnosis and Treatment
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 1 companies

Generated from the cited public record · current as of 30 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Neuro-Oncology / Glioma1 trialGlioma1 trialDiffuse Intrinsic Pontine Glioma1 trialSarcoma

Research focus

OpenAlex concept fingerprint
Glioma Diagnosis and TreatmentRadiation Therapy and DosimetrySarcoma Diagnosis and TreatmentAdvanced Radiotherapy TechniquesMeningioma and schwannoma management

Works with

trial sponsors and companies reporting payments
GT Medical Technologies, IncClinical trials—Industry payments1Proton Collaborative GroupClinical trials1Industry payments—University of CincinnatiClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
74publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,646citations

Total citations across indexed works.

16h-index

Hirsch index (OpenAlex). i10-index 22.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
1companies · 2022–2022

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 30 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 30 Oct 2026

1 company reported payments to CMS in program years 2022–2022. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Medicare prescribing footprint (2019)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    100%
    Corticosteroid100%
    Prednisone100%
    Part D<11 patients
Where care is delivered (Part B)11% facility · 89% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 30 Oct 2026

17 congress contributions (2014–2026) across ASCO, ASTRO per OpenAlex. The most recent:

All 17 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

All 0 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human
    Article478 citations2003
    doi.org ↗
  2. 02
    A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy
    Article360 citations2006
    doi.org ↗
  3. 03
    Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy
    Article122 citations2003
    doi.org ↗
  4. 04
    Wilms tumor
    Review84 citations2020
    doi.org ↗
  5. 05
    Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN
    Article65 citations2018
    doi.org ↗
All 74 cited works: search, sort and filter.Explore →

Network

Updated 30 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

John C. Breneman27Ralph E. Vatner13Timothy D. Struve10Norberto O. Andaluz10John A. Kalapurakal8Andrew J. Frankart8Jonathan Andrew Forbes8T.D. Struve7Rekha T. Chaudhary6Ronald E. Warnick6James I. Geller6L. Yogendran5Trent Ryan Hummel5Maryam Fouladi5Evangelia Galani Kranias5Matthew C. Hagen5Soma Sengupta4Arnold C. Paulino4Lionel M.L. Chow4Kobra Haghighi4Ady Kendler4John Thomas Lucas4Mariko Dawn DeWire4K. Wang4Brian Weiss4Anita Mahajan4Vinita Takiar4Ralph Salloum4Kyle Wang4Elizabeth Anne Mullen4Peter F. Ehrlich4Damien Charles Weber4S. Sengupta4Jonathan Sackett4Christine E. Fuller4Mark William McDonald4Sarah M. C. Sittenfeld4Gerald W. Dorn4Frances A. Collichio3Kevin Shiue3

Background & recognition

Updated 30 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.